Načítá se...
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
Inactivating mutations of the tumor suppressor gene Liver Kinase B1 (LKB1) are frequently detected in non-small-cell lung cancer (NSCLC) and cervical carcinoma. Moreover, LKB1 expression is epigenetically regulated in several tumor types. LKB1 has an established function in the control of cell metab...
Uloženo v:
| Vydáno v: | Oxid Med Cell Longev |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6874879/ https://ncbi.nlm.nih.gov/pubmed/31781355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8730816 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|